Vistagen Therapeutics (VTGN) Operating Margin Growth (5y) (2016 - 2026)

Vistagen Therapeutics (VTGN) Operating Margin Growth (5y) (2016 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Vertex Pharmaceuticals	139.20 Bn	131.35 Bn	2.84 Bn
2	Regeneron Pharmaceuticals	86.09 Bn	78.10 Bn	3.93 Bn
3	Argenx Se	65.25 Bn	60.07 Bn	1.37 Bn
4	Moderna	59.04 Bn	53.90 Bn	52.00 Mn
5	BeOne Medicines	42.04 Bn	36.94 Bn	1.53 Bn
6	Alnylam Pharmaceuticals	31.61 Bn	28.30 Bn	992.69 Mn
7	BioNTech SE	28.04 Bn	9.65 Bn	668.28 Mn
8	Insmed	27.50 Bn	26.33 Bn	358.27 Mn
9	Royalty Pharma	27.34 Bn	26.50 Bn	-
10	Vistagen Therapeutics	10.41 Mn	10.41 Mn	-

Download Data